Search

everythinglearnresearchcommunity

for

Search:↓

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Protein analysis shows aging changes in scalp cell types from women.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may harm male fertility and damage the reproductive system.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Hair loss doesn't affect COVID-19 severity.